QT Imaging (QTI) Competitors

QT Imaging logo
$1.80 -0.08 (-4.26%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$1.80 +0.00 (+0.28%)
As of 11/16/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

QTI vs. KEQU, OM, HYPR, MBOT, and NRXS

Should you buy QT Imaging stock or one of its competitors? QT Imaging's main competitors and comparable companies include Kewaunee Scientific (KEQU), Outset Medical (OM), Hyperfine (HYPR), Microbot Medical (MBOT), and NeurAxis (NRXS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does QT Imaging compare to Kewaunee Scientific?

QT Imaging (NASDAQ:QTI) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

QT Imaging presently has a consensus target price of $9.67, indicating a potential upside of 437.04%. Given QT Imaging's stronger consensus rating and higher possible upside, equities analysts plainly believe QT Imaging is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has higher revenue and earnings than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M1.40-$21.08M-$1.12N/A
Kewaunee Scientific$282M0.36$9.62M$2.7612.76

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 25.4% of QT Imaging shares are owned by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Kewaunee Scientific has a net margin of 2.97% compared to QT Imaging's net margin of -54.63%. Kewaunee Scientific's return on equity of 11.61% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-54.63% -259.62% -37.01%
Kewaunee Scientific 2.97%11.61%4.82%

QT Imaging has a beta of 0.05, suggesting that its share price is 95% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

In the previous week, QT Imaging had 9 more articles in the media than Kewaunee Scientific. MarketBeat recorded 11 mentions for QT Imaging and 2 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.79 beat QT Imaging's score of 0.64 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Kewaunee Scientific beats QT Imaging on 10 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Outset Medical?

QT Imaging (NASDAQ:QTI) and Outset Medical (NASDAQ:OM) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

QT Imaging has a beta of 0.05, meaning that its share price is 95% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.93, meaning that its share price is 93% more volatile than the broader market.

QT Imaging has higher earnings, but lower revenue than Outset Medical. QT Imaging is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M1.40-$21.08M-$1.12N/A
Outset Medical$119.48M0.54-$81.65M-$3.87N/A

In the previous week, QT Imaging had 8 more articles in the media than Outset Medical. MarketBeat recorded 11 mentions for QT Imaging and 3 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.94 beat QT Imaging's score of 0.64 indicating that Outset Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Outset Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

QT Imaging presently has a consensus target price of $9.67, suggesting a potential upside of 437.04%. Outset Medical has a consensus target price of $10.00, suggesting a potential upside of 194.99%. Given QT Imaging's stronger consensus rating and higher possible upside, equities analysts plainly believe QT Imaging is more favorable than Outset Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

24.2% of QT Imaging shares are owned by institutional investors. 25.4% of QT Imaging shares are owned by insiders. Comparatively, 2.5% of Outset Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

QT Imaging has a net margin of -54.63% compared to Outset Medical's net margin of -58.33%. Outset Medical's return on equity of -66.98% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-54.63% -259.62% -37.01%
Outset Medical -58.33%-66.98%-28.40%

Summary

QT Imaging beats Outset Medical on 10 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Hyperfine?

QT Imaging (NASDAQ:QTI) and Hyperfine (NASDAQ:HYPR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 25.4% of QT Imaging shares are owned by company insiders. Comparatively, 26.3% of Hyperfine shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

QT Imaging has a beta of 0.05, meaning that its share price is 95% less volatile than the broader market. Comparatively, Hyperfine has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market.

QT Imaging currently has a consensus price target of $9.67, suggesting a potential upside of 437.04%. Hyperfine has a consensus price target of $2.03, suggesting a potential upside of 231.91%. Given QT Imaging's higher probable upside, equities research analysts plainly believe QT Imaging is more favorable than Hyperfine.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Hyperfine
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67

QT Imaging has a net margin of -54.63% compared to Hyperfine's net margin of -156.42%. Hyperfine's return on equity of -91.18% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-54.63% -259.62% -37.01%
Hyperfine -156.42%-91.18%-55.49%

QT Imaging has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M1.40-$21.08M-$1.12N/A
Hyperfine$11.40M5.68-$35.57M-$0.30N/A

In the previous week, QT Imaging had 5 more articles in the media than Hyperfine. MarketBeat recorded 11 mentions for QT Imaging and 6 mentions for Hyperfine. QT Imaging's average media sentiment score of 0.64 beat Hyperfine's score of 0.18 indicating that QT Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hyperfine
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

QT Imaging beats Hyperfine on 10 of the 17 factors compared between the two stocks.

How does QT Imaging compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and QT Imaging (NASDAQ:QTI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Microbot Medical currently has a consensus target price of $5.08, suggesting a potential upside of 688.85%. QT Imaging has a consensus target price of $9.67, suggesting a potential upside of 437.04%. Given Microbot Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Microbot Medical is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Microbot Medical has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market. Comparatively, QT Imaging has a beta of 0.05, meaning that its share price is 95% less volatile than the broader market.

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 3.9% of Microbot Medical shares are held by company insiders. Comparatively, 25.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to QT Imaging's net margin of -54.63%. Microbot Medical's return on equity of -21.87% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -21.87% -20.76%
QT Imaging -54.63%-259.62%-37.01%

Microbot Medical has higher earnings, but lower revenue than QT Imaging. Microbot Medical is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot MedicalN/AN/A-$13.14M-$0.26N/A
QT Imaging$18.92M1.40-$21.08M-$1.12N/A

In the previous week, QT Imaging had 5 more articles in the media than Microbot Medical. MarketBeat recorded 11 mentions for QT Imaging and 6 mentions for Microbot Medical. QT Imaging's average media sentiment score of 0.64 beat Microbot Medical's score of 0.30 indicating that QT Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Microbot Medical
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
QT Imaging
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Microbot Medical beats QT Imaging on 9 of the 15 factors compared between the two stocks.

How does QT Imaging compare to NeurAxis?

NeurAxis (NASDAQ:NRXS) and QT Imaging (NASDAQ:QTI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

NeurAxis presently has a consensus price target of $13.00, suggesting a potential upside of 170.83%. QT Imaging has a consensus price target of $9.67, suggesting a potential upside of 437.04%. Given QT Imaging's higher possible upside, analysts clearly believe QT Imaging is more favorable than NeurAxis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeurAxis
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

NeurAxis has higher earnings, but lower revenue than QT Imaging. NeurAxis is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeurAxis$6.53M7.83-$14.63M-$1.06N/A
QT Imaging$18.92M1.40-$21.08M-$1.12N/A

NeurAxis has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, QT Imaging has a beta of 0.05, meaning that its stock price is 95% less volatile than the broader market.

QT Imaging has a net margin of -54.63% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
NeurAxis-492.76% N/A -641.25%
QT Imaging -54.63%-259.62%-37.01%

In the previous week, QT Imaging had 8 more articles in the media than NeurAxis. MarketBeat recorded 11 mentions for QT Imaging and 3 mentions for NeurAxis. QT Imaging's average media sentiment score of 0.64 beat NeurAxis' score of 0.31 indicating that QT Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeurAxis
0 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
QT Imaging
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 21.1% of NeurAxis shares are held by insiders. Comparatively, 25.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

QT Imaging beats NeurAxis on 10 of the 15 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$30.27M$5.96B$7.84B$12.17B
Dividend YieldN/A1.69%2.46%4.43%
P/E Ratio-1.6136.8434.7128.60
Price / Sales1.405.438.635.70
Price / CashN/A23.9521.9322.50
Price / Book10.004.374.323.70
Net Income-$21.08M$143.12M$3.52B$392.17M
7 Day Performance-20.35%-3.75%-4.44%-3.21%
1 Month Performance-25.00%-2.79%-3.49%-5.66%
1 Year Performance-71.39%0.25%0.19%-5.97%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
2.6985 of 5 stars
$1.80
-4.3%
$9.67
+437.0%
-71.4%$30.27M$18.92MN/A32
KEQU
Kewaunee Scientific
1.2552 of 5 stars
$35.94
+7.6%
N/A-12.9%$96.72M$282M13.021,231
OM
Outset Medical
3.2991 of 5 stars
$3.86
-7.4%
$10.00
+159.1%
-27.6%$78.70M$119.48MN/A310
HYPR
Hyperfine
2.0603 of 5 stars
$0.68
-4.5%
$2.03
+198.1%
-46.9%$75.43M$11.40MN/A102
MBOT
Microbot Medical
2.7221 of 5 stars
$1.03
-7.2%
$5.08
+393.5%
-68.9%$74.55MN/AN/A22

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners